Study cohort of people with acute hidrosadenitis
Part of Skin clinical trials.
This study follows people diagnosed with acute hidrosadenitis over time to better understand the condition. Joining may help researchers learn how patients do in real life and what may be needed to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A dermatologist has diagnosed you with acute hidrosadenitis
- You agree to take part in this study
- You are not under major legal guardianship
- You are not considered a protected person for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a group (cohort) of patients treated for acne at a hospital to better understand acne care in real life. It may help improve future care by sharing what treatments people receive and how they do over time.
This study collects information from people with hidradenitis suppurativa (a skin condition causing painful lumps) to better understand the condition and improve care worldwide.
This study looks at the real-life impact of hidradenitis suppurativa (HS), a skin condition, on people like you. You'll answer questions about your symptoms and daily life to help researchers understand the burden of HS.
This study explores how people with hidradenitis suppurativa (HS) participate in research. You'll report your health regularly using a device, and the goal is to better understand patient experiences.
This study looks at the physical and biological (body-related) characteristics of hidradenitis suppurativa. It may help researchers understand the condition better and improve future care.
This study enrolls people with hidradenitis suppurativa (HS) to better understand the condition over time and store optional health information and samples. Being in the registry may help researchers learn about patterns in HS and support future research.
Hear when a new Acute Hidrosadenitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.